Snowden Capital Advisors LLC Teva Pharmaceutical Industries LTD Transaction History

Snowden Capital Advisors LLC

$3.12 Billion
Q4 2024

A detailed history of Snowden Capital Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 32,563 shares of TEVA stock, worth $535,986. This represents 0.02% of its overall portfolio holdings.

Number of Shares

32,563

Previous 36,913 11.78%

Holding current value

$535,986

Previous $665,000 7.82%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$16.43 - $22.77 $71,470 - $99,049	-4,350 Reduced 11.78%	32,563 $717,000
Q3 2024 Nov 14, 2024	BUY	$15.81 - $18.96 $83,555 - $100,203	5,285 Added 16.71%	36,913 $665,000
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $20,039 - $27,283	-1,568 Reduced 4.72%	31,628 $513,000
Q1 2024 May 15, 2024	BUY	$10.67 - $14.43 $44,003 - $59,509	4,124 Added 14.19%	33,196 $468,000
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $1,047 - $1,371	129 Added 0.45%	29,072 $303,000
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $139,030 - $198,880	18,587 Added 179.48%	28,943 $295,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $74,563 - $98,071	10,356 New	10,356 $77,000
Q1 2022 May 16, 2022	SELL	$7.33 - $9.39 $300 - $384	-41 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $323 - $417	41 New	41 $0
Q1 2020 Jan 08, 2024	SELL	$6.69 - $13.45 $89,646 - $180,230	-13,400 Closed	0 $0
Q4 2019 Jan 08, 2024	SELL	$6.53 - $10.72 $101,495 - $166,620	-15,543 Reduced 53.7%	13,400 $1.31 Million

Others Institutions Holding TEVA

# of Institutions

678

Shares Held

578M

Call Options Held

25.5M

Put Options Held

14.7M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Teva Pharmaceutical Industries LTD Transaction History